Zevra Therapeutics (ZVRA) EBIT Margin (2019 - 2026)
Zevra Therapeutics (ZVRA) posted EBIT Margin of 42.26% for Q2 2026, up 316.54 percentage points from -274.28% a year earlier but down 101.71 percentage points from the prior quarter.
Powered by 
Analysis
Zevra Therapeutics (ZVRA) EBIT Margin (2019 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBIT Margin at Zevra Therapeutics was 60.50%, up 252.59 percentage points year-over-year; for FY2025, it came in at -59.10%, up 309.37 percentage points from FY2024.
- Annual EBIT Margin shows a five-year change of -16.89 percentage points (FY2020 to FY2025).
- In prior years, Zevra Therapeutics' EBIT Margin was -368.47% in FY2024 (-187.84 pp), -180.63% in FY2023 (+238.27 pp), -418.91% in FY2022 (-445.88 pp) and 26.98% in FY2021 (+69.19 pp).
- Quarterly EBIT Margin has run from a low of -1905.15% in Q2 2022 to a high of 143.97% in Q1 2026 over five years.
- On a year-over-year basis, EBIT Margin has increased in each of the last six quarters, with an average year-over-year change of +251.30 percentage points over the last eight quarters.
- The strongest year-over-year quarter for EBIT Margin in the past five years was Q2 2023, with a gain of 1831.34 percentage points; the weakest was Q2 2022, with a drop of 1953.82 percentage points.
- According to Business Quant data, EBIT Margin for the three prior quarters was 143.97% (Q1 2026), 27.27% (Q4 2025) and 15.87% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 37.40% |
| 10 | Zevra Therapeutics | 672.94 Mn | -139.77 Mn | 38.18 Mn | 42.26% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 42.26% |
| Mar 31, 2026 | 143.97% |
| Dec 31, 2025 | 27.27% |
| Sep 30, 2025 | 15.87% |
| Jun 30, 2025 | -274.28% |
| Mar 31, 2025 | -26.28% |
| Dec 31, 2024 | -128.34% |
| Sep 30, 2024 | -738.00% |
| Jun 30, 2024 | -534.84% |
| Mar 31, 2024 | -598.13% |
| Dec 31, 2023 | -117.31% |
| Sep 30, 2023 | -530.71% |
| Jun 30, 2023 | -73.81% |
| Mar 31, 2023 | -404.00% |
| Dec 31, 2022 | -460.58% |
| Sep 30, 2022 | -230.55% |
| Jun 30, 2022 | -1,905.15% |
| Mar 31, 2022 | -46.89% |
| Dec 31, 2021 | -110.07% |
| Sep 30, 2021 | -113.08% |
API Access
Zevra Therapeutics EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=ZVRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "ZVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=ZVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();